Using Sequence Data To Infer the Antigenicity of Influenza Virus

ABSTRACT The efficacy of current influenza vaccines requires a close antigenic match between circulating and vaccine strains. As such, timely identification of emerging influenza virus antigenic variants is central to the success of influenza vaccination programs. Empirical methods to determine influenza virus antigenic properties are time-consuming and mid-throughput and require live viruses. Here, we present a novel, experimentally validated, computational method for determining influenza virus antigenicity on the basis of hemagglutinin (HA) sequence. This method integrates a bootstrapped ridge regression with antigenic mapping to quantify antigenic distances by using influenza HA1 sequences. Our method was applied to H3N2 seasonal influenza viruses and identified the 13 previously recognized H3N2 antigenic clusters and the antigenic drift event of 2009 that led to a change of the H3N2 vaccine strain. IMPORTANCE This report supplies a novel method for quantifying antigenic distance and identifying antigenic variants using sequences alone. This method will be useful in influenza vaccine strain selection by significantly reducing the human labor efforts for serological characterization and will increase the likelihood of correct influenza vaccine candidate selection. This report supplies a novel method for quantifying antigenic distance and identifying antigenic variants using sequences alone. This method will be useful in influenza vaccine strain selection by significantly reducing the human labor efforts for serological characterization and will increase the likelihood of correct influenza vaccine candidate selection.

[1]  N. Wingreen,et al.  Differential neutralization efficiency of hemagglutinin epitopes, antibody interference, and the design of influenza vaccines , 2009, Proceedings of the National Academy of Sciences.

[2]  Malbea A Lapete,et al.  Morbidity and Mortality Weekly Report Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (acip) Centers for Disease Control and Prevention Epidemiology Program Office Early Release 1 Prevention and Control of Influenza Recommendations of the Advis , 2022 .

[3]  Katrina Sleeman,et al.  Human Infections with Novel Reassortant Influenza A(H3N2)v Viruses, United States, 2011 , 2012, Emerging infectious diseases.

[4]  Gavin J. D. Smith,et al.  Genetic evolution of the neuraminidase of influenza A (H3N2) viruses from 1968 to 2009 and its correspondence to haemagglutinin evolution. , 2012, The Journal of general virology.

[5]  N. Ferguson,et al.  Improving influenza vaccine virus selectionReport of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14–16 June 2010 , 2011, Influenza and other respiratory viruses.

[6]  Elaine L. Baker.  Centers for Disease Control and Prevention Advisory Committee on Immunization Practices (ACIP) , 2009 .

[7]  T. Tatusova,et al.  The Influenza Virus Resource at the National Center for Biotechnology Information , 2007, Journal of Virology.

[8]  Erin Burns,et al.  Estimates of deaths associated with seasonal influenza --- United States, 1976-2007. , 2010, MMWR. Morbidity and mortality weekly report.

[9]  A. Osterhaus,et al.  Mismatch between the 1997/1998 influenza vaccine and the major epidemic A(H3N2) virus strain as the cause of an inadequate vaccine‐induced antibody response to this strain in the elderly , 2000, Journal of medical virology.

[10]  W. Fitch,et al.  Predicting the evolution of human influenza A. , 1999, Science.

[11]  Ruhong Zhou,et al.  Single mutation induced H3N2 hemagglutinin antibody neutralization: a free energy perturbation study. , 2008, The journal of physical chemistry. B.

[12]  Jinn-Moon Yang,et al.  Co-evolution positions and rules for antigenic variants of human influenza A/H3N2 viruses , 2009, BMC Bioinformatics.

[13]  E. Nobusawa,et al.  Studies on the molecular basis for loss of the ability of recent influenza A (H1N1) virus strains to agglutinate chicken erythrocytes. , 1996, The Journal of general virology.

[14]  Sarah Cobey,et al.  Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14–16 June 2010 , 2013, Influenza and other respiratory viruses.

[15]  Keiji Fukuda,et al.  Influenza-associated hospitalizations in the United States. , 2004, JAMA.

[16]  Keiji Fukuda,et al.  Mortality associated with influenza and respiratory syncytial virus in the United States. , 2003, JAMA.

[17]  A S Perelson,et al.  Variable efficacy of repeated annual influenza vaccination. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Chao A. Hsiung,et al.  Bioinformatics models for predicting antigenic variants of influenza A/H3N2 virus , 2008, Bioinform..

[19]  Hong Jin,et al.  Two residues in the hemagglutinin of A/Fujian/411/02-like influenza viruses are responsible for antigenic drift from A/Panama/2007/99. , 2005, Virology.

[20]  Arthur Chun-Chieh Shih,et al.  Simultaneous amino acid substitutions at antigenic sites drive influenza A hemagglutinin evolution , 2007, Proceedings of the National Academy of Sciences.

[21]  Stuart Berman,et al.  Sexually transmitted diseases treatment guidelines, 2010. , 2010, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[22]  T M Moran,et al.  Antigen-presenting B cells and helper T cells cooperatively mediate intravirionic antigenic competition between influenza A virus surface glycoproteins. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[23]  R. F. Smith,et al.  Pattern-induced multi-sequence alignment (PIMA) algorithm employing secondary structure-dependent gap penalties for use in comparative protein modelling. , 1992, Protein engineering.

[24]  Nimrod D. Rubinstein,et al.  Computational characterization of B-cell epitopes. , 2008, Molecular immunology.

[25]  E. Nobusawa,et al.  Change in receptor-binding specificity of recent human influenza A viruses (H3N2): a single amino acid change in hemagglutinin altered its recognition of sialyloligosaccharides. , 2000, Virology.

[26]  Zhipeng Cai,et al.  A Computational Framework for Influenza Antigenic Cartography , 2010, PLoS Comput. Biol..

[27]  I. Wilson,et al.  Structural basis of immune recognition of influenza virus hemagglutinin. , 1990, Annual review of immunology.

[28]  N. Cox,et al.  The total influenza vaccine failure of 1947 revisited: Major intrasubtypic antigenic change can explain failure of vaccine in a post-World War II epidemic , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[29]  N. Cox,et al.  Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. , 2009 .

[30]  W. S. Valdar,et al.  Scoring residue conservation , 2002, Proteins.

[31]  S. Izui,et al.  Resistance to tolerance induction to human gammaglobulin (HGG) in autoimmune BXSB/MpJ mice: functional analysis of antigen-presenting cells and HGG-specific T helper cells. , 1988, Clinical and experimental immunology.

[32]  J. Gerberding,et al.  Morbidity and Mortality Weekly Report Inside: Continuing Education Examination Applying Public Health Strategies to Primary Immunodeficiency Diseases a Potential Approach to Genetic Disorders Centers for Disease Control and Prevention Epidemiology Program Office Recommendations and Reports 1 Applyin , 2022 .

[33]  L. Brammer,et al.  Evaluation of rapid influenza diagnostic tests for influenza A (H3N2)v virus and updated case count--United States, 2012. , 2012, MMWR. Morbidity and mortality weekly report.

[34]  J. Yewdell,et al.  The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype) , 1982, Cell.

[35]  A. Lapedes,et al.  Mapping the Antigenic and Genetic Evolution of Influenza Virus , 2004, Science.

[36]  Zhipeng Cai,et al.  AntigenMap 3D: an online antigenic cartography resource , 2012, Bioinform..

[37]  Min-Shi Lee,et al.  Predicting Antigenic Variants of Influenza A/H3N2 Viruses , 2004, Emerging infectious diseases.

[38]  R. Tibshirani.  Regression Shrinkage and Selection via the Lasso , 1996 .

[39]  N. Cox,et al.  Prevention and Control of Influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2006, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[40]  K. Mansfield,et al.  Viral tropism and the pathogenesis of influenza in the Mammalian host. , 2007, The American journal of pathology.

[41]  Amanda Balish,et al.  Genetic analysis and antigenic characterization of swine origin influenza viruses isolated from humans in the United States, 1990-2010. , 2012, Virology.

[42]  Keiji Fukuda,et al.  Detection of Antibody to Avian Influenza A (H5N1) Virus in Human Serum by Using a Combination of Serologic Assays , 1999, Journal of Clinical Microbiology.

[43]  Fang Fang,et al.  DAS181 Inhibits H5N1 Influenza Virus Infection of Human Lung Tissues , 2009, Antimicrobial Agents and Chemotherapy.

[44]  Yi Guan,et al.  Extent of Antigenic Cross-Reactivity among Highly Pathogenic H5N1 Influenza Viruses , 2011, Journal of Clinical Microbiology.

[45]  James Paulson,et al.  Receptor Specificity of Influenza A H3N2 Viruses Isolated in Mammalian Cells and Embryonated Chicken Eggs , 2010, Journal of Virology.

[46]  Ron A M Fouchier,et al.  Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses. , 2008, Vaccine.

[47]  James E. Crowe,et al.  Structural Basis of Preexisting Immunity to the 2009 H1N1 Pandemic Influenza Virus , 2010, Science.

[48]  Werner Braun,et al.  Exact and efficient analytical calculation of the accessible surface areas and their gradients for macromolecules , 1998, J. Comput. Chem..

[49]  Tong Zhang,et al.  Identifying antigenicity-associated sites in highly pathogenic H5N1 influenza virus hemagglutinin by using sparse learning. , 2012, Journal of molecular biology.

[50]  New A/H3N2 Influenza Variant: a Small Genetic Evolution but a Heavy Burden on the Italian Population during the 2004-2005 Season , 2005, Journal of Clinical Microbiology.

[51]  Update: Influenza A (H3N2)v transmission and guidelines - five states, 2011. , 2012, MMWR. Morbidity and mortality weekly report.

[52]  J. Kaldor,et al.  Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. , 2010, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[53]  Derrick J. Zwickl.  Genetic algorithm approaches for the phylogenetic analysis of large biological sequence datasets under the maximum likelihood criterion , 2006 .

[54]  Fang Fang,et al.  Inhibition of Neuraminidase Inhibitor-Resistant Influenza Virus by DAS181, a Novel Sialidase Fusion Protein , 2009, PloS one.

[55]  Robert C. Edgar,et al.  MUSCLE: multiple sequence alignment with high accuracy and high throughput. , 2004, Nucleic acids research.

[56]  Smith Rf,et al.  Pattern-induced multi-sequence alignment (PIMA) algorithm employing secondary structure-dependent gap penalties for use in comparative protein modelling. , 1992 .

[57]  G. Air,et al.  Mechanism of antigenic variation in an individual epitope on influenza virus N9 neuraminidase , 1990, Journal of virology.

[58]  U. Bauer,et al.  [Centers for Disease Control and Prevention (CDC)]. , 2000, Annales de dermatologie et de venereologie.